RepliCel Life Sciences Inc. (REPCF)

[AugustStockInformer]

Great new interview with Lee Buckler, the CEO:

https://www.twst.com/interview/Interview-with-the-President-CEO-and-Director-RepliCel-Life-Sciences-Inc-OTCMKTS-REPCF

TWST: How would you describe the core technology for your company, particularly when it comes to what you feel represents the most important intellectual property that you have?

Mr. Buckler: We are a biotech company with a companion medical device that has near-term applications well beyond our biologics. At the core of it, we are in the regenerative medicine space where we are taking a patient’s cells and then manufacturing a product that we then inject back into the patient for orthopedic sports injury and aesthetic applications. We are developing two different biologics comprised of different cell populations and a proprietary injector. We believe that device has significant potential to improve the way anything is injected through the skin, over the longer term for our biologics but in the near term for the dermal fillers that represent a $2 billion-plus existing market...